eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | neuropathy, peripheral |
| Comorbidity | C0011847|diabetes |
| Sentences | 68 |
| PubMedID- 24009454 | However, the effect of vve on peripheral nerve damage in diabetes has not been well-studied. |
| PubMedID- 23983297 | [9] diabetes is associated with peripheral neuropathy, so the nerve may already be functionally abnormal at the time of intubation, and this may worsen thereafter resulting in cord dysfunction. |
| PubMedID- 26075029 | Is cognitive impairment associated with the presence and severity of peripheral neuropathy in patients with type 2 diabetes mellitus. |
| PubMedID- 20690070 | Aim: the aim of this prospective study was to evaluate the contribution of the indicator test for sudomotor function neuropad(r) to the early diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus. |
| PubMedID- 20151233 | It is seen most commonly in the foot and ankle, secondary to peripheral neuropathy in patients with diabetes mellitus. |
| PubMedID- 23818897 | This study compares the effectiveness of michigan neuropathy screening instrument (mnsi), neurothesiometer, and electromyography (emg) in detecting diabetic peripheral neuropathy in patients with diabetes type 2. |
| PubMedID- 20148083 | peripheral neuropathy affects patients with diabetes as well as patients that have impaired glucose tolerance and are considered to be prediabetic [1–5]. |
| PubMedID- 24552681 | Aims: peripheral neuropathy in diabetes (pnd) plays a central role in foot ulceration with diabetes, and leads to an abnormal microvascular structure, including arteriovenous shunting. |
| PubMedID- 21860819 | Gastroesophageal reflux disease in type ii diabetes mellitus with or without peripheral neuropathy. |
| PubMedID- 22309476 | Postural strategies in diabetes patients with peripheral neuropathy determined using cross-correlation functions. |
| PubMedID- 23931803 | Both type 1 (insulin-dependent) and type 2 diabetes are commonly complicated by peripheral nerve disorders. |
| PubMedID- 24593991 | It is found that prevalence of peripheral neuropathy in diabetes was lower in people with good glycemic control (a1c < 7%) rather than those with poor glycemic control (a1c ≥ 9%) [32,34]. |
| PubMedID- 21876303 | We excluded 6 patients who showed cerebral infarct (4 patients) and diabetes mellitus with peripheral neuropathy (2 patients); finally, 4 patients (39.75 +/- 9.84 years) were included in this study. |
| PubMedID- 21727664 | This study was carried out to evaluate the usefulness of simple bed side screening modalities for peripheral neuropathy in patients with diabetes mellitus. |
| PubMedID- 24705616 | However, the peripheral neuropathy associated with diabetes masks symptoms of atherosclerosis, making the true prevalence of disease in the peripheral arteries difficult to ascertain without additional testing and presenting a challenge to early identification and prevention of disease progression (12,17). |
| PubMedID- 26089210 | Conclusions: this study provides strong evidence of clinically meaningful improvements in visual function, hscrp and peripheral neuropathy in patients with diabetes, both with and without retinopathy, and without affecting glycaemic control. |
| PubMedID- 25785201 | Fifteen patients (58%) were cigarette smokers, and two patients (8%) had noninsulin dependent diabetes with no peripheral neuropathy. |
| PubMedID- 22519862 | Conclusion: there was a high prevalence of peripheral neuropathy in patients with type 2 diabetes in korea and those patients were far more likely to have complications or co-morbidities. |
| PubMedID- 25527161 | Several studies showed a possible association between vitamin d deficiency and diabetic peripheral neuropathy (dpn) in patients with type 2 diabetes, but no definite conclusion was available. |
| PubMedID- 22490586 | Methods: all the 274 patients (include 137 type 2 diabetes mellitus with diabetic peripheral neuropathy and 137 type 2 diabetes mellitus without diabetic peripheral neuropathy) from the metabolic disease hospital in tianjin participated in the study. |
| PubMedID- 24753654 | Thirty adult patients with type 2 diabetes mellitus with symptoms of peripheral neuropathy for ≥6 months were randomized to receive pregabalin 75 mg, methylcobalamin 750 μg, and ala 100 mg (pma, n = 15); or pregabalin 75 mg (pg, n = 15) for 12 weeks. |
| PubMedID- 24003572 | Non-healing foot ulcers in diabetes may be due to peripheral neuropathy and/or vasculopathy. |
| PubMedID- 20627580 | peripheral neuropathy associated with diabetes mellitus often causes severe neuropathic pain that is difficult to alleviate. |
| PubMedID- 21095715 | It has been well documented that subjects with peripheral neuropathy resulting from diabetes mellitus are at high risk of developing foot ulceration. |
| PubMedID- 25623477 | Three out of five patients were positive for longstanding history of type 2 diabetes mellitus with diabetic peripheral neuropathy and previous lower extremity amputations in the foot. |
| PubMedID- 24472435 | The purpose of this study was to evaluate the effectiveness of semmes–weinstein monofilament ten gram in 3, 4, eight and ten points in the screening of diabetic peripheral neuropathy in patients with diabetes mellitus. |
| PubMedID- 25395956 | However, there have been no reports on the association of vegf 936c/t polymorphism and type 2 diabetes with peripheral neuropathy so far. |
| PubMedID- 21672340 | Prevalence of painful diabetic peripheral neuropathy among patients with diabetes mellitus in the middle east region. |
| PubMedID- 20508012 | Five patients had diabetes with peripheral neuropathy, 2 had critical limb ischemia, 1 had alcohol-induced neuropathy, 1 had lupus, and 1 was an active smoker. |
| PubMedID- 20836855 | Thus, peripheral neuropathy associated with diabetes may not be the only factor contributing to impaired postural control in people with diabetes. |
| PubMedID- 23121425 | Impact of action cues, self-efficacy and perceived barriers on daily foot exam practice in type 2 diabetes mellitus patients with peripheral neuropathy. |
| PubMedID- 22482054 | For example, diabetes can lead to peripheral neuropathy, and diabetic patients with pre-existing nerve damage may be predisposed to more severe forms of capn [2–4]. |
| PubMedID- 25692057 | It is seen most commonly in the foot and ankle secondary to peripheral neuropathy associated with diabetes mellitus. |
| PubMedID- 22642973 | The present study aims to describe the community prevalence, patterns and predictors of distal peripheral neuropathy among patients with diabetes mellitus in sri lanka with a view of identifying differential risk factors, which may lead to improved preventive measures and care for diabetic patients in the south asia region. |
| PubMedID- 24479039 | Foot care knowledge and practices and the prevalence of peripheral neuropathy among people with diabetes attending a secondary care rural hospital in southern india. |
| PubMedID- 22269030 | Aims: to investigate the relationship between retinal nerve fibre layer thickness and peripheral neuropathy in patients with type 2 diabetes, particularly in those who are at higher risk of foot ulceration. |
| PubMedID- 23914216 | Prevalence and related risk-factors of peripheral neuropathy in children with insulin-dependent diabetes mellitus. |
| PubMedID- 26069072 | Objective: painful peripheral neuropathy in people with type 2 diabetes is a disabling complication. |
| PubMedID- 23218892 | Metanx in type 2 diabetes with peripheral neuropathy: a randomized trial. |
| PubMedID- 25579387 | Hyperuricemia was also significantly associated with increased risk of peripheral neuropathy in patients with type 2 diabetes (risk ratio [rr] = 2.83, 95%ci 2.13-3.76, p < 0.00001). |
| PubMedID- 21561371 | Thirty-eight patients with diabetes having peripheral neuropathies were enrolled, randomized, and subdivided in two groups: an experimental group of 19 participants with diabetes (72.9 +/- 5.6 years old) and a control group of 19 participants with diabetes (73.2 +/- 5.4 years old). |
| PubMedID- 25031965 | Additional medical history includes hypertension and diabetes with existing peripheral neuropathy. |
| PubMedID- 20920432 | Method: the gait of 20 nondiabetic individuals and 46 diabetes patients with and without peripheral neuropathy was analyzed [mean age 59.0 (2.9) and 61.1(4.4) years, mean body mass index (bmi) 24.0 (2.8), and 26.3 (2.0)]. |
| PubMedID- 23238789 | Aims/hypothesis: the aim was to evaluate the efficacy and safety of transcutaneous frequency-modulated electromagnetic neural stimulation (frequency rhythmic electrical modulation system, frems) as a treatment for symptomatic peripheral neuropathy in patients with diabetes mellitus. |
| PubMedID- 24915443 | Aims: elevated dynamic plantar pressures are a consistent finding in diabetes patients with peripheral neuropathy with implications for plantar foot ulceration. |
| PubMedID- 24381887 | diabetes with peripheral neuropathy have more incidence of delayed bera tracing. |
| PubMedID- 25410212 | Of the many patterns of peripheral nerve disorders in diabetes mellitus (dm), isolated clinical involvement of single nerves, though less common than distal symmetric polyneuropathy and perhaps polyradiculoneuropathy, constitute an important collection of characteristic syndromes. |
| PubMedID- 25672193 | Frequency of peripheral neuropathy in patients with diabetes mellitus. |
| PubMedID- 25810640 | Evaluation of dna damage in type 2 diabetes mellitus patients with and without peripheral neuropathy: a study in south indian population. |
| PubMedID- 26000014 | Diabetic neuropathy (dn) is a neuropathic disorder characterized by diabetes mellitus (dm) with peripheral neuropathy lacking other possible causes. |
Page: 1 2